Richard Gunderlock

Rich is currently Director of Corporate Validation Services at Astra Zeneca/MedImmune Biologics, responsible for regulatory compliant Validation Standards and Procedures for MedImmune Operations. Within ISPE Rich is an active member of the C&Q CoP. Rich joined MedImmune in 2008 after being a Validation Consultant with Sanofi-Pasteur and Amgen and after 28 years with Merck. Rich has been a project leader, implementing bio/pharmaceutical processes and facilities in the US, Puerto Rico, France, Russia, and China. Today’s talk is about Rich’s most cherished project: the Merck-China Hepatitis B Technology Transfer Project. Education: Master of Business Administration - Drexel University Bachelor of Science Mechanical Engineering - University of Michigan Bachelor of Science Applied Mathematics - Central Michigan University